Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adverse Events
Biotech
Neurogene acts as gene therapy puts person in critical condition
Neurogene has dropped plans to keep studying the high dose of its Rett syndrome gene therapy amid safety concerns.
Nick Paul Taylor
Nov 18, 2024 8:33am
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
Syndax stock slips after AML drug hits midstage trial goal
Nov 12, 2024 2:00pm
Dyne shakes up C-suite after hazy DMD data drop
Sep 3, 2024 11:49am
Galapagos pauses CAR-T cell therapy trial over Parkinsonism case
Aug 2, 2024 8:49am
ASCO: J&J's radioligand spurs responses, but 4 deaths mar data
May 24, 2024 10:51am
